Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.
Smokers who have certain variations of the estrogen-related ESR1 gene are at higher risk of developing lupus, a study suggests. The research, “Estrogen receptor alpha gene (ESR1) polymorphism and ... Read more
A combination of voclosporin and standard therapy eliminated the inflamed-kidney condition lupus nephritis in twice as many patients as those who received standard care alone, according to a Phase ... Read more
Youngsters with an allergy-susceptibility condition known as atopy have worse cases of lupus when diagnosed and poorer outcomes than patients without atopy, a study reports. The research, “Atopy in ... Read more
Women with systemic lupus erythematosus (SLE) receiving immunosuppressive treatment may be at risk of developing high-grade cervical dysplasia and cervical cancer, compared to patients receiving hydroxychloroquine therapy alone. Although ... Read more
Aurinia Pharmaceuticals has started a Phase 3 clinical trial of voclosporin’s ability to treat lupus nephritis, a lupus-generated condition that causes kidneys to become inflamed and eventually fail. The ... Read more
Aurinia Pharmaceuticals’ product candidate voclosporin continues to show promise in patients with lupus nephritis (LN), according to the company. In addition to meeting complete and partial remission endpoints at ... Read more
Clinical trials with lupus patients should have a longer duration and a careful selection of patients based on certain parameters such as disease severity and treatment, recommends the Lupus ... Read more